Physician profile
Kara Birch
NPI 1750893582
$821.39
in general payments reported to CMS, 2019-2025
16 companies · $569 in 2025
The $569 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $253 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $210.72 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $89.71 | 2025 | Ozempic, Wegovy |
| Amgen INC. | $68.71 | 2024-2025 | Evenity, Prolia, Tezspire |
| Harmony Biosciences LLC | $60.98 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $57.67 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Lilly USA, LLC | $54.98 | 2025 | Jardiance |
| Phathom Pharmaceuticals, INC. | $53.66 | 2025 | Voquezna |
| Exact Sciences Corporation | $49.74 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $39.13 | 2025 | |
| Shield Therapeutics INC | $23.27 | 2024 | |
| Glaxosmithkline, LLC. | $22.56 | 2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.68 | 2025 | Ofev |
| Verona Pharma, INC. | $20.61 | 2025 | Ohtuvayre |
| Philips North America LLC | $17.41 | 2025 | Vest Therapy Und |
| Seqirus USA INC | $15.58 | 2024 | Flucelvax, Fluad |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.98 | 2025 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Birch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.